REDEFINING MONOCLONAL ANTIBODY THERAPY Trademark
REDEFINING MONOCLONAL ANTIBODY THERAPY is a USPTO trademark filed by ImClone Systems Incorporated. Status: Abandoned.
Trademark Facts
| Mark | REDEFINING MONOCLONAL ANTIBODY THERAPY |
|---|---|
| Serial Number | 76604657 |
| Status | Abandoned |
| Filing Date | 2004-07-21 |
| Mark Type | Word |
| Nice Classes | 044 (Medical Services) |
| Owner | ImClone Systems Incorporated |
| Attorney of Record | Robert M. Kunstadt |
| Prosecution Events | 16 |
| Latest Event | ABN6 on 2006-08-28 |
Goods & Services
MEDICAL INFORMATION SERVICES RENDERED TO THE PUBLIC BY MEANS OF A GLOBAL COMPUTER INFORMATION NETWORK, PERTAINING TO CANCER, CANCER RESEARCH, TREATMENT OF CANCER, PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF CANCER, VACCINES AND DIAGNOSTIC PREPARATIONS; "MONOCLONAL ANTIBODY THERAPY"